MENU

Speakers


  • Christopher Austin

    Christopher Austin

    Director, National Center for Advancing Translational Sciences

    BIOGRAPHY
  • Emily Balskus

    Emily Balskus

    Associate Professor, Harvard University's Department of Chemistry and Chemical Biology

    BIOGRAPHY
  • Jeff Blaney

    Jeff Blaney

    Director of Computational Chemistry & Cheminformatics Genentech

    BIOGRAPHY
  • Mark Blaskovich

    Mark Blaskovich

    Program Coordinator: Community for Open Antimicrobial Drug Discovery, University of Queensland

    BIOGRAPHY
  • Sean Ekins

    Sean Ekins

    CEO, Collaborations Pharmaceuticals

    BIOGRAPHY
  • Enoch Huang

    Enoch Huang

    Executive Director, Computational Sciences, Pfizer

    BIOGRAPHY
  • Nancy J Kelley

    Nancy J Kelley

    Founder, Nancy J Kelley + Associates

    BIOGRAPHY
  • Derek Lowe

    Derek Lowe

    Research Fellow, Vertex

    BIOGRAPHY
  • Lisa Marcaurelle

    Lisa Marcaurelle

    Vice President, Discovery Chemistry, H3 Biomedicine

    BIOGRAPHY
  • Vic Myer

    Vic Myer

    Chief Technology Officer, Editas

    BIOGRAPHY
  • Robert Plenge

    Robert Plenge

    Vice President, Merck

    BIOGRAPHY
  • Christina White

    Christina White

    Professor of Chemistry, University of Illinois

    BIOGRAPHY
  • Hagop Youssoufian

    Hagop Youssoufian

    Chief Medical Officer, BIND Therapeutics

    BIOGRAPHY
SEP 16, 2015

C&EN's Virtual Symposium: Advances in Drug Discovery and Development

C&EN is delighted to present its second annual virtual symposium highlighting groundbreaking research in drug discovery, chemical synthesis, informatics and drug development.

On September 16, 2015, a renowned group of scientists from biotech, pharma and academia will present the latest research findings and new technologies that are driving the design, discovery and development of new drugs – from traditional small molecules and biologics to cutting-edge gene-editing and immunological technologies. Speakers will present the latest advances in identifying promising drug targets, verifying lead compounds, and new strategies that are delivering more powerful, personalized drugs to the marketplace.

Last year, more than 7,400 scientists signed up to attend C&EN’s inaugural virtual event. We invite you to join an even larger audience this September. If you can’t make the live lectures, all presentations will be archived and available on demand for three months.

PROGRAM
This year’s keynote and event speakers are driving R&D inside leading commercial and academic institutions, including Merck, Pfizer, Genentech, Editas Medicine, BIND Therapeutics, Syros, The Scripps Research Institute, and many more. Among the many themes to be covered are:

*Organic synthesis for novel drugs
*Personalized and precision medicine
*Structure-based drug design
*Business and collaborative strategies
*Gene regulation in cancer
*Informatics in the R&D environment
*Genome editing technologies

REGISTRATION

Register now for free, then log in on September 16 to visit the virtual conference and trade show. It’s like being there but without the cost or hassle of travel! Listen to 1-2 key talks or attend a stream of presentations throughout the day.

• Participate in live Q&A sessions
• “Walk the floor” in our virtual exhibition hall
• Live-chat with peers and vendors in the booth
• Download valuable resources
• Re-watch your favorite talks

The C&EN virtual symposium provides a perfect blend of interactivity and convenience. Build your personal agenda ahead of time; if you can’t attend the live symposium, watch replays on-demand at your convenience.


Speakers
  • Christopher Austin

    Director, National Center for Advancing Translational Sciences
    BIOGRAPHY
  • Emily Balskus

    Associate Professor, Harvard University's Department of Chemistry and Chemical Biology
    BIOGRAPHY
  • Jeff Blaney

    Director of Computational Chemistry & Cheminformatics Genentech
    BIOGRAPHY
  • Mark Blaskovich

    Program Coordinator: Community for Open Antimicrobial Drug Discovery, University of Queensland
    BIOGRAPHY
  • Sean Ekins

    CEO, Collaborations Pharmaceuticals
    BIOGRAPHY
  • Enoch Huang

    Executive Director, Computational Sciences, Pfizer
    BIOGRAPHY
  • Nancy J Kelley

    Founder, Nancy J Kelley + Associates
    BIOGRAPHY
  • Derek Lowe

    Research Fellow, Vertex
    BIOGRAPHY
  • Lisa Marcaurelle

    Vice President, Discovery Chemistry, H3 Biomedicine
    BIOGRAPHY
  • Vic Myer

    Chief Technology Officer, Editas
    BIOGRAPHY
  • Robert Plenge

    Vice President, Merck
    BIOGRAPHY
  • Christina White

    Professor of Chemistry, University of Illinois
    BIOGRAPHY
  • Hagop Youssoufian

    Chief Medical Officer, BIND Therapeutics
    BIOGRAPHY

You May Also Like

Agenda

  • SEP 16, 2015 2:00 PM PDT

    Enabling the Best Structure-Based Design Engine:a Human Expert

    Jeff Blaney
    Director of Computational Chemistry & Cheminformatics Genentech
    BIOGRAPHY
  • SEP 16, 2015 2:00 PM PDT

    Engineering Biology for a Sustainable Future

    Nancy J Kelley
    Founder, Nancy J Kelley + Associates
    BIOGRAPHY
  • SEP 16, 2015 1:00 PM PDT

    Q&A with Derek Lowe

    Derek Lowe
    Research Fellow, Vertex
    BIOGRAPHY
  • SEP 16, 2015 12:00 PM PDT

    Developing Accurate Nanomedicines: The BIND Therapeutics Approach

    Hagop Youssoufian
    Chief Medical Officer, BIND Therapeutics
    BIOGRAPHY
  • SEP 16, 2015 12:00 PM PDT

    The Functionalization of C-H Bonds

    Christina White
    Professor of Chemistry, University of Illinois
    BIOGRAPHY
  • SEP 16, 2015 11:00 AM PDT

    Gut reactions: Understanding and manipulating chemistry from the human microbiota

    Emily Balskus
    Associate Professor, Harvard University's Department of Chemistry and Chemical Biology
    BIOGRAPHY
  • SEP 16, 2015 10:00 AM PDT

    Catalyzing Translational Innovation

    Christopher Austin
    Director, National Center for Advancing Translational Sciences
    BIOGRAPHY
  • SEP 16, 2015 9:00 AM PDT

    Transforming translational medicine for effective drug discovery

    Robert Plenge
    Vice President, Merck
    BIOGRAPHY
  • SEP 16, 2015 8:00 AM PDT

    Diversity-Oriented Synthesis for Discovery of Novel Therapeutics

    Lisa Marcaurelle
    Vice President, Discovery Chemistry, H3 Biomedicine
    BIOGRAPHY
  • SEP 16, 2015 7:00 AM PDT

    Editas Medicine, Creating a novel class of genome editing therapeutics

    Vic Myer
    Chief Technology Officer, Editas
    BIOGRAPHY
  • SEP 16, 2015 7:00 AM PDT

    Open Science for Rare and Neglected Diseases

    Sean Ekins
    CEO, Collaborations Pharmaceuticals
    BIOGRAPHY
  • SEP 16, 2015 6:00 AM PDT

    Of soft drinks and software: a framework to sustain innovation in computational molecular design

    Enoch Huang
    Executive Director, Computational Sciences, Pfizer
    BIOGRAPHY
  • SEP 16, 2015 5:00 AM PDT

    Synthetic Chemists to Aid the Community for Open Antimicrobial Drug Discovery

    Mark Blaskovich
    Program Coordinator: Community for Open Antimicrobial Drug Discovery, University of Queensland
    BIOGRAPHY

Sponsors & Partners

For information on becoming a sponsor or exhibitor, please click here.


Help

Loading Comments...